Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · IEX Real-Time Price · USD
0.373
-0.005 (-1.40%)
At close: Jul 2, 2024, 4:00 PM
0.370
-0.003 (-0.80%)
After-hours: Jul 2, 2024, 7:58 PM EDT
Company Description
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine.
Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation.
The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors.
Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems, Inc.
| Country | United States |
| Founded | 2016 |
| IPO Date | Nov 11, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Ms. Jennifer Ernst |
Contact Details
Address: 47685 Lakeview Blvd Fremont, California 94538 United States | |
| Phone | (888)276-6888 |
| Website | tivichealth.com |
Stock Details
| Ticker Symbol | TIVC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001787740 |
| CUSIP Number | 888705100 |
| ISIN Number | US8887052095 |
| Employer ID | 81-4016391 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jennifer Ernst | Co-Founder, Chief Executive Officer and Director |
| Dr. Blake Gurfein Ph.D. | Chief Scientific Officer |
| Kimberly Ann Bambach | Interim Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 28, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 28, 2024 | ARS | Filing |
| Jun 28, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 18, 2024 | 8-K | Current Report |
| May 30, 2024 | 8-K | Current Report |
| May 22, 2024 | 8-K | Current Report |
| May 15, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| May 15, 2024 | 10-Q | Quarterly Report |
| May 15, 2024 | 8-K | Current Report |
| May 13, 2024 | 8-K | Current Report |